Biotech Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics January 8, 2025
Biotech Vesper Bio initiates Phase Ib/IIa proof of concept study of VES001 in asymptomatic patients with gene mutations that cause frontotemporal dementia (FTD) January 7, 2025
Biotech U.S. FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application January 7, 2025
Biotech WILLOW ANNOUNCES CANCELLATION OF PREVIOUSLY ANNOUNCED NON-BROKERED OFFERING TO PURSUE LESS DILUTIVE ALTERNATIVES January 3, 2025
Biotech Nona Biosciences Announces Update on Its Collaborator DualityBio’s Antibody-Drug Conjugate (ADC) Collaboration with BeiGene January 3, 2025
Biotech WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year January 2, 2025
Biotech Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA January 1, 2025
Biotech CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy January 1, 2025
Search
Biotech
January 8, 2025
January 7, 2025
January 7, 2025
January 3, 2025
January 3, 2025
January 3, 2025
January 2, 2025
January 2, 2025
January 1, 2025
January 1, 2025
